450 related articles for article (PubMed ID: 28691229)
21. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection.
Gurusamy KS; Li J; Sharma D; Davidson BR
Cochrane Database Syst Rev; 2009 Oct; (4):CD008085. PubMed ID: 19821442
[TBL] [Abstract][Full Text] [Related]
22. Tranexamic acid for patients with nasal haemorrhage (epistaxis).
Joseph J; Martinez-Devesa P; Bellorini J; Burton MJ
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD004328. PubMed ID: 30596479
[TBL] [Abstract][Full Text] [Related]
23. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
[TBL] [Abstract][Full Text] [Related]
24. Methods to decrease blood loss and transfusion requirements for liver transplantation.
Gurusamy KS; Pissanou T; Pikhart H; Vaughan J; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD009052. PubMed ID: 22161443
[TBL] [Abstract][Full Text] [Related]
25. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
[TBL] [Abstract][Full Text] [Related]
26. Fresh frozen plasma for cardiovascular surgery.
Desborough M; Sandu R; Brunskill SJ; Doree C; Trivella M; Montedori A; Abraha I; Stanworth S
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD007614. PubMed ID: 26171897
[TBL] [Abstract][Full Text] [Related]
27. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Radford M; Estcourt LJ; Sirotich E; Pitre T; Britto J; Watson M; Brunskill SJ; Fergusson DA; Dorée C; Arnold DM
Cochrane Database Syst Rev; 2024 May; 5(5):CD011305. PubMed ID: 38780066
[TBL] [Abstract][Full Text] [Related]
28. Pathogen-reduced platelets for the prevention of bleeding.
Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627
[TBL] [Abstract][Full Text] [Related]
29. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
[TBL] [Abstract][Full Text] [Related]
30. Continuation versus discontinuation of antiplatelet therapy for bleeding and ischaemic events in adults undergoing non-cardiac surgery.
Lewis SR; Pritchard MW; Schofield-Robinson OJ; Alderson P; Smith AF
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012584. PubMed ID: 30019463
[TBL] [Abstract][Full Text] [Related]
31. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.
Desborough M; Estcourt LJ; Doree C; Trivella M; Hopewell S; Stanworth SJ; Murphy MF
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010982. PubMed ID: 27548292
[TBL] [Abstract][Full Text] [Related]
32. Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.
Laupacis A; Fergusson D
Anesth Analg; 1997 Dec; 85(6):1258-67. PubMed ID: 9390590
[TBL] [Abstract][Full Text] [Related]
33. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
34. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
[TBL] [Abstract][Full Text] [Related]
35. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding.
Wikkelsø A; Wetterslev J; Møller AM; Afshari A
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD007871. PubMed ID: 27552162
[TBL] [Abstract][Full Text] [Related]
36. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ
Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522
[TBL] [Abstract][Full Text] [Related]
37. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
38. Alarm interventions for nocturnal enuresis in children.
Caldwell PH; Codarini M; Stewart F; Hahn D; Sureshkumar P
Cochrane Database Syst Rev; 2020 May; 5(5):CD002911. PubMed ID: 32364251
[TBL] [Abstract][Full Text] [Related]
39. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children.
McNicol ED; Tzortzopoulou A; Schumann R; Carr DB; Kalra A
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD006883. PubMed ID: 27643712
[TBL] [Abstract][Full Text] [Related]
40. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disorders.
Ray S; Ray A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD010338. PubMed ID: 27841443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
